Relapsed Angioimmunoblastic T Cell Lymphoma with Fulminant Leukemic Involvement.

Altahan, Rahaf; AlMugairi, Areej; Almahayni, Muhamed Hitham; Damlaj, Moussab; Al-Zghoul, Ahmad

Altahan, Rahaf; AlMugairi, Areej; Almahayni, Muhamed Hitham; Damlaj, Moussab; Al-Zghoul, Ahmad.

Afiliação

Altahan R; Hematology Section, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
AlMugairi A; Division of Hematopathology, Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Almahayni MH; Division of Hematopathology, Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Damlaj M; Division of Hematology and HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Al-Zghoul A; Division of Hematology and HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Am J Case Rep ; 23: e936448, 2022 Aug 12.

Article em En | MEDLINE | ID: mdl-35957503

Assuntos

Linfadenopatia Imunoblástica; Linfoma não Hodgkin; Linfoma de Células T; Humanos; Linfadenopatia Imunoblástica/diagnóstico; Linfadenopatia Imunoblástica/terapia; Infiltração Leucêmica; Linfoma de Células T/diagnóstico; Linfoma de Células T/terapia; Recidiva Local de Neoplasia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma de Células T / Linfadenopatia Imunoblástica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google